Your browser doesn't support javascript.
Rapid Recovery in COVID-19 Patients with Chronic Hepatitis B Virus Infection Treated with Tenofovir Disoproxil Fumarate.
Chen, Xiliu; Liu, Di; Yang, Dongliang; Zheng, Xin.
  • Chen X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Liu D; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Yang D; Pritzker School of Medicine, University of Chicago, Chicago, IL, USA.
  • Zheng X; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
J Clin Transl Hepatol ; 9(2): 269-273, 2021 Apr 28.
Article in English | MEDLINE | ID: covidwho-1234939
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic continues worldwide. We report here two cases of chronic hepatitis B patients with acute respiratory syndrome coronavirus 2 infection treated with tenofovir disoproxil fumarate who demonstrated a favorable outcome. This report adds some evidence that concurrent HBV infection may not worsen COVID-19 infection and tenofovir disoproxil fumarate treatment may have partial positive effect on COVID-19 rapid recovery.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: J Clin Transl Hepatol Year: 2021 Document Type: Article Affiliation country: JCTH.2020.00129

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: J Clin Transl Hepatol Year: 2021 Document Type: Article Affiliation country: JCTH.2020.00129